NO914481L - Fremgangsmaate for fremstilling og anvendelse av substituerte azoler - Google Patents

Fremgangsmaate for fremstilling og anvendelse av substituerte azoler

Info

Publication number
NO914481L
NO914481L NO91914481A NO914481A NO914481L NO 914481 L NO914481 L NO 914481L NO 91914481 A NO91914481 A NO 91914481A NO 914481 A NO914481 A NO 914481A NO 914481 L NO914481 L NO 914481L
Authority
NO
Norway
Prior art keywords
mean
azols
substituted
procedure
manufacturing
Prior art date
Application number
NO91914481A
Other languages
English (en)
Other versions
NO914481D0 (no
Inventor
Heinz-Werner Kleemann
Hermann Gerhards
Bernward Schoelkens
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO914481D0 publication Critical patent/NO914481D0/no
Publication of NO914481L publication Critical patent/NO914481L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/68—Halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/70—One oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Azoler med formel. der X, Y og Z står for N eller CR, der Rblant annet kan bety hydrogen, klor, metoksy, benzyloksy. L kan blant annet bety -CE-, A betyr en aromatisk eller heterocykllsk rest og T en binding eller en toverdig rest, Ri kan blant annet bety (CR3-C5 )-alkyl og E kan blant annet bety følgende formel. Det blir beskrevet en fremgangsmåte for fremstilling, og midler som inneholder disse forbindelsene og deres anvendelse som helnlngsmiddel.
NO91914481A 1990-11-16 1991-11-15 Fremgangsmaate for fremstilling og anvendelse av substituerte azoler NO914481L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4036645A DE4036645A1 (de) 1990-11-16 1990-11-16 Substituierte azole, verfahren zu deren herstellung, deren enthaltende mittel und deren verwendung

Publications (2)

Publication Number Publication Date
NO914481D0 NO914481D0 (no) 1991-11-15
NO914481L true NO914481L (no) 1992-05-18

Family

ID=6418438

Family Applications (1)

Application Number Title Priority Date Filing Date
NO91914481A NO914481L (no) 1990-11-16 1991-11-15 Fremgangsmaate for fremstilling og anvendelse av substituerte azoler

Country Status (17)

Country Link
EP (1) EP0485929A1 (no)
JP (1) JPH04283569A (no)
KR (1) KR920009802A (no)
CN (1) CN1061410A (no)
AU (1) AU8785591A (no)
BR (1) BR9104948A (no)
CA (1) CA2055636A1 (no)
CS (1) CS347091A3 (no)
DE (1) DE4036645A1 (no)
FI (1) FI915381A (no)
HU (1) HUT59673A (no)
IE (1) IE913991A1 (no)
IL (1) IL100058A0 (no)
MX (1) MX9102098A (no)
NO (1) NO914481L (no)
PT (1) PT99521A (no)
ZA (1) ZA919059B (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4036706A1 (de) * 1990-11-17 1992-05-21 Hoechst Ag Verfahren zur behandlung der cardialen sowie der vasculaeren hypertrophie und hyperplasie
US5616599A (en) * 1991-02-21 1997-04-01 Sankyo Company, Limited Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use
DE4200954A1 (de) * 1991-04-26 1992-10-29 Bayer Ag Heterocyclisch substituierte phenylessigsaeurederivate
RU2109736C1 (ru) * 1992-12-17 1998-04-27 Санкио Компани Лимитед Производные бифенила и способ их получения
US5300668A (en) * 1993-03-10 1994-04-05 Pfizer Inc. Certain esters of 1-(4-X-methylphenyl)cyclopent-3-ene-1-carboxylic acid, wherein X is a trialkylsilyloxy, bromo or hydroxy group, as intermediates
DE19645313A1 (de) 1996-11-04 1998-05-07 Basf Ag Substituierte 3-Benzylpyrazole
SE9903028D0 (sv) 1999-08-27 1999-08-27 Astra Ab New use
PE20070182A1 (es) 2005-07-29 2007-03-06 Wyeth Corp Derivados cianopirrol-fenil amida como moduladores del receptor de progesterona
PE20070404A1 (es) 2005-07-29 2007-05-10 Wyeth Corp Compuestos derivados de cianopirrol-sulfonamida como moduladores del receptor de progesterona
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
ES2393885T7 (es) 2007-06-04 2014-01-30 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
ES2522968T3 (es) 2008-06-04 2014-11-19 Synergy Pharmaceuticals Inc. Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
AU2009270833B2 (en) 2008-07-16 2015-02-19 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CA2905435A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
JP2016514671A (ja) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼのアゴニストおよびその使用
US10011637B2 (en) 2013-06-05 2018-07-03 Synergy Pharmaceuticals, Inc. Ultra-pure agonists of guanylate cyclase C, method of making and using same
WO2023274257A1 (zh) * 2021-07-01 2023-01-05 诸葛国琴 一种咪唑类化合物、其中间体及应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1329614C (en) * 1987-05-02 1994-05-17 Rainer Buerstinghaus N-substituted azoles
CA1338238C (en) * 1988-01-07 1996-04-09 David John Carini Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids

Also Published As

Publication number Publication date
IL100058A0 (en) 1992-08-18
KR920009802A (ko) 1992-06-25
IE913991A1 (en) 1992-05-20
DE4036645A1 (de) 1992-05-21
FI915381A (fi) 1992-05-17
BR9104948A (pt) 1992-06-23
FI915381A0 (fi) 1991-11-14
CN1061410A (zh) 1992-05-27
CS347091A3 (en) 1992-06-17
JPH04283569A (ja) 1992-10-08
HU913583D0 (en) 1992-01-28
AU8785591A (en) 1992-05-21
CA2055636A1 (en) 1992-05-17
PT99521A (pt) 1992-09-30
HUT59673A (en) 1992-06-29
EP0485929A1 (de) 1992-05-20
NO914481D0 (no) 1991-11-15
ZA919059B (en) 1992-07-29
MX9102098A (es) 1992-07-08

Similar Documents

Publication Publication Date Title
NO914481L (no) Fremgangsmaate for fremstilling og anvendelse av substituerte azoler
DK0503162T3 (da) Asolderivater, fremgangsmåde til deres fremstilling og deres anvendelse
NO20025821L (no) 2-aminokarbonyl-9H-purinderivater
CA2017934A1 (en) Nitrogen-containing titanocenes, and the use thereof
CA2040905A1 (en) Carbohydrate derivatives comprising a trisaccharide unit
CA2017932A1 (en) Oxygen-containing titanocenes, and the use thereof
NO971625L (no) Nye peptider med immunomodulatoriske effekter
CA2080249A1 (en) Preparation of substituted piperidines
MY131693A (en) Arylacetic acid derivatives
CA2298461A1 (en) Heterocyclic substituted 4-benzoyl-pyrazole as herbicides
NO884523D0 (no) Joderte polymerer, fremgangsmaate for deres fremstilling og deres anvendelse som kontrastmidler.
DK0490816T3 (da) Fluorforbindelser som aromatase-inhibitorer.
CA2188796A1 (en) Heterocyclylbenzonitriles
CA2051894A1 (en) Substituted 5-Alkoxy-1,2,4-Triazol-3-(Thi)Ones
BG98238A (en) Substituted benzothiazole derivatives, methods for their preparation and their application as herbicides
NO943765L (no) Aryloksybenzen-herbicidmidler
ATE149159T1 (de) Heteroarylmethylbenzole-aromatasehemmer
NO950665L (no) Nye polyjoderte forbindelser, fremgangsmåte for deres fremstilling og kontrastmidler inneholdende disse
WO2000012480A3 (de) Substituierte 3-aryl-pyrazole
PL348356A1 (en) Substituted 1,3,5-triazines
NO965267D0 (no) Glucuronyl-forbindelser, og framgangsmåte for framstilling av samme
ATE135010T1 (de) Neue beta-galactosidase-substrate für den cedia
MY107258A (en) 1-methoxypyrimidinyl-n-nitrophenyl-1h-1,2,4-triazole-3- sulphonamides, processes for their preparation and their use as herbicides.
IL67400A0 (en) 3,7alpha-diazacyclohepta(j,k)fluorene derivatives,their preparation and pharmaceutical compositions containing them
TW328085B (en) Novel amino acid derivatives for the treatment or prevention of multi-drug resistance